EMErik Madssen

Erik Madssen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Erik Madssen has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    High-intensity progressive resistance training to prevent falls in community-dwelling adults aged 80 years and older with reduced muscle strength: protocol for the ReFit randomised controlled trial

    by Jonathan Berg, Karina Hammer Tømmerdal, Jeff S. Coombes, Turid Follestad, Øyvind O. Salvesen, Erik Madssen, Geir Selbæk, Håvard Dalen, Gudrun M. W. Bjørnelv, Brooke L. Devlin, et al.

    Introduction: Falls are a major cause of injury-related morbidity, mortality, and healthcare utilisation among older adults, with the greatest burden occurring in those aged ≥80 years. Multicomponent exercise programmes that include balance and resistance exercises reduce falls, whereas the effect of resistance training delivered as a standalone fall-prevention intervention remains uncertain. Existing resistance-training trials have generally been small, underpowered for fall outcomes, and have produced inconsistent findings, despite reduced muscle strength being an important modifiable risk factor in the oldest old. The resistance training prescription used in these studies has not always aligned with recommendations for optimal strength adaptations in terms of intensity or progressive overload, which may explain this uncertain efficacy. Therefore, this study aims to determine whether 12 months of high-intensity progressive resistance training reduces fall rates in community-dwelling adults aged ≥80 years with reduced muscle strength. Methods and analysis: This single-centre, randomised controlled trial conducted in Trondheim, Norway, includes 241 community-dwelling adults aged ≥80 years with reduced muscle strength. Participants are randomly assigned (1:1) to either standard care with written physical activity guidance or a twice-weekly high-intensity progressive resistance training intervention for 12 months. The primary outcome is the rate of falls over 12 months. Secondary outcomes include time to first fall, fall-related injuries, muscular function, physical performance, balance, body composition, cardiometabolic health, cognition, and participant-reported outcomes. Cost-effectiveness is assessed from a healthcare perspective over the 12-month intervention period using costs and quality-adjusted life years. Analyses follow the intention-to-treat principle, using negative binomial regression for the primary outcome. The first participant was included on 30 March 2023, and the last participant was included on 29 September 2025. The 12-month intervention period is expected to be completed by September 2026. Ethics and dissemination: The study has received approval from the Regional Committee for Medical and Health Research Ethics in Norway (REK; reference number 462261). All participants provided written informed consent before participating. Findings will be shared via peer-reviewed publications, conference presentations, and communication with stakeholders and the public. Trial registration number: ClinicalTrials.gov ( NCT05691166 ), registered 11 January 2023. Available at: https://clinicaltrials.gov/study/NCT05691166

  • Open Access

    Beta-blocker therapy and physical activity after myocardial infarction: a preplanned sub-study of the BETAMI trial

    by Erik Madssen, Elise Sverre, Johanne E Nyen, Therese L F Holmager, Anna M D Kristensen, Arnhild Bakken, Jarle Jortveit, Thor Edvardsen, Terje Steigen, Sigrun Halvorsen, et al.

    Aims: To investigate the effect of long-term beta-blocker therapy on physical activity (PA) level after myocardial infarction (MI) in patients without heart failure. Methods and results: The BETAMI trial randomized patients hospitalized with a MI without heart failure (LVEF ≥40%) to beta-blocker or no beta-blocker. In this preplanned sub-study, PA level was assessed by guideline-recommended PA level (≥30 min moderate activity ≥5 days/week) or not and self-reported hours/week with light to moderate and vigorous PA. Between-group differences in PA from baseline before randomization to 18-months were estimated by linear mixed models. Exploratory analysis assessed treatment effects on a composite of all-cause mortality and major adverse cardiovascular events using a Cox proportional hazards model. Of the 2867 randomized patients, 2185 (76%) responded to the PA questions and were included in this analysis. Mean age was 62.5 (SD 10.1) years, and 20.6% were women. No differences in guideline-recommended PA level or mean hours of light to moderate and vigorous PA were reported between the beta-blocker and non-beta-blocker group at baseline or during 18-month follow-up. At 12-month follow-up, 37.0% in the beta-blocker group and 36.7% in the no beta-blocker group reported guideline-recommended PA level (OR 0.97, 95% CI 0.69–1.37). Exploratory, hypothesis-generating analyses did not demonstrate a statistically significant interaction (P for interaction = 0.06) between treatment assignment and baseline PA level for recurrent clinical events. Conclusion: Beta-blocker therapy did not result in a change in PA level in post-MI patients without heart failure during the 18-month follow-up. Registration: ClinicalTrials.gov. URL: https://clinicaltrials.gov/search?term==NCT03646357. Unique identifier: NCT03646357, registered on 23 August 2018.


  • Open Access

    Physical activity patterns from mid- to late adulthood and risk of sarcopenia in older adults: the HUNT study

    by Karina Hammer Tømmerdal, Javaid Nauman, Erik Madssen, Jari Antero Laukkanen, Arnt Erik Tjønna, Ulrik Wisløff, Jonathan Berg

    Background: While cross-sectional studies suggest that physical activity (PA) is associated with a lower risk of sarcopenia, the long-term PA patterns remain poorly characterized. We aimed to examine whether PA patterns across mid- to late adulthood are associated with sarcopenia in older age. Methods: We included 4702 individuals (mean age 76.4 ± 5.0 years, 53% female) from the HUNT4 (Trøndelag Health Study) 70+ cohort with PA data across three prior waves (HUNT1–3). PA was categorized as active or inactive at each time point (1984-86, 1995-97, 2006-08) according to the World Health Organization 2020 guidelines. Sarcopenia at HUNT4 (2017-19) was defined according to the European Working Group on Sarcopenia (EWGSOP2) criteria as probable (low strength) or confirmed (low strength and low muscle mass). Logistic regression analyses were used to examine associations between long-term PA patterns and sarcopenia. Results: PA showed a clear inverse dose-response relationship with sarcopenia, with stronger associations for confirmed than probable sarcopenia. Compared with persistent inactivity, being active at all three time points was associated with 78% lower odds of confirmed sarcopenia at HUNT4 (OR 0.22, 95% CI: 0.08-0.66). Participants active at two and one time points had 40% (OR 0.60, 0.38-0.95) and 26% (OR 0.74, 0.55-1.00) lower odds, respectively. Associations varied by PA pattern, with lower odds observed among those becoming active (OR 0.57, 0.39–0.84) but not among those becoming inactive. Conclusion: Long-term PA shows a clear dose–response relationship with sarcopenia risk in later life. While sustained activity across adulthood confers the greatest benefit, initiating PA even later in life remains associated with lower odds of sarcopenia.

  • Open Access

    Sex-specific and polygenic effects underlying resting heart rate and associated risk of cardiovascular disease

    by Ada N Nordeidet, Marie Klevjer, Karsten Øvretveit, Erik Madssen, Ulrik Wisløff, Ben M Brumpton, Anja Bye

    Aims: Resting heart rate (RHR) is associated with cardiovascular disease (CVD) and mortality. This study aimed to identify genetic loci associated with RHR, develop a genome-wide polygenic risk score (PRS) for RHR, and assess associations between the RHR PRS and CVD outcomes, to better understand the biological mechanisms linking RHR to disease. Sex-specific analyses were conducted to potentially elucidate different pathways between the sexes. Methods and results: We performed a genome-wide meta-analysis of RHR (n = 550 467) using two independent study populations, The Trøndelag Health Study (HUNT) and the UK Biobank (UKB), comprising 69 155 and 481 312 participants, respectively. We also developed a genome-wide PRS for RHR using UKB and tested for association between the PRS and 13 disease outcomes in HUNT. We identified 403, 253, and 167 independent single nucleotide polymorphisms (SNPs) significantly associated with RHR in the total population, women, and men, respectively. The sex-specified analyses indicated differences in the genetic contribution to RHR and revealed loci significantly associated with RHR in only one of the sexes. The SNPs were mapped to genes enriched in heart tissue and cardiac conduction pathways, as well as disease-pathways, including dilated cardiomyopathy. The PRS for RHR was associated with increased risk of hypertension and dilated cardiomyopathy, and decreased risk of atrial fibrillation. Conclusion: Our findings provide insight into the pleiotropic effects of the RHR variants, contributing towards an improved understanding of mechanisms linking RHR and disease. In addition, the sex-specific results might contribute to a more refined understanding of RHR as a risk factor for the different diseases.


  • Open Access

    Insight into the relationship between resting heart rate and atrial fibrillation: a Mendelian randomization study

    by Marie Klevjer, Humaira Rasheed, Pål R Romundstad, Erik Madssen, Ben M Brumpton, Anja Bye

    Aims: A low resting heart rate (RHR) implies a more efficient heart function and a lower risk of cardiovascular disease. However, observational studies have reported a U-shaped association between RHR and atrial fibrillation (AF). In contrast, Mendelian randomization (MR) studies have found an inverse causal association between RHR and AF. Hence, the causal nature of the relationship is not clear. The aim is to investigate the causal association and its shape between RHR on AF using linear and non-linear MR (NLMR). Methods and results: Linear and non-linear MR were performed on individual-level data in the Trøndelag Health Study (HUNT) and UK Biobank (UKB). HUNT consists of 69 155 individuals with 7,062 AF cases, while UKB provides data on 431 852 individuals with 20 452 AF cases. The linear MR found an inverse relationship between RHR and AF with an OR = 0.95 [95% confidence interval (CI): 0.93–0.98] and OR = 0.96 (95% CI: 0.95–0.97) per unit decrease in RHR in HUNT and UKB, respectively. The NLMR was supportive of an inverse linear relationship in both HUNT and UKB for RHR values <90 beats per minute (bpm). Several sensitivity analyses were also consistent. Conclusion: In contrast with the current observational knowledge of RHR and AF, an inverse causal association between RHR and AF was demonstrated in both linear and non-linear MR for RHR values up to 90 bpm. Further exploring the underlying mechanisms of the genetic instrument for RHR may shed light on whether pleiotropy is biasing this association.


  • High-intensity interval training induces beneficial effects on coronary atheromatous plaques: a randomized trial

    by Elisabeth Kleivhaug Vesterbekkmo, Inger-Lise Aamot Aksetøy, Turid Follestad, Hans Olav Nilsen, Knut Hegbom, Ulrik Wisløff, Rune Wiseth, Erik Madssen

    Coronary atheroma volume is associated with risk of coronary events in coronary artery disease (CAD). Exercise training is a cornerstone in primary and secondary prevention of CAD, but the effect of exercise on coronary atheromatous plaques is largely unknown. We assessed the effect of six months supervised high intensity interval training (HIIT) on coronary plaque geometry using intravascular ultrasound in patients with stable CAD following percutaneous coronary intervention (PCI). Sixty patients were randomized to two sessions of weekly supervised HIIT at 85-95% of peak heart rate (n = 30) or to follow contemporary preventive guidelines (control group, n = 30). The study endpoints were change in percent atheroma volume (PAV) and total atheroma volume (TAV) normalized for segment length (TAVnorm) at six-month follow-up. The change in average PAV for matched coronary segments from baseline to follow-up showed a significant between-group difference (-1.4, 95% CI: -2.7 to -0.1, p = 0.036). There was a significant reduction in the HIIT group (-1.2, 95% CI: -2.1 to -0.2, p = 0.017) while not in the control group (0.2, 95% CI: -0.7 to 1.1, p = 0.616). TAVnorm was reduced (-9 mm3, 95% CI: -14.7 to -3.4, p = 0.002) after HIIT, with a significant between-group difference (-12.0 mm3, 95% CI: -19.9 to -4.2, p = 0.003). In patients with established CAD, a regression of atheroma volume was observed in those undergoing six months of supervised HIIT compared with patients following contemporary preventive guidelines. Our study indicates that high intensity interval training counteracts atherosclerotic coronary disease progression and reduces atheroma volume in residual coronary atheromatous plaques following PCI.


  • Open Access

    Stent edge vascular response and in-stent geometry after aerobic exercise

    by Maria Dalen Taraldsen, Vibeke Videm, Knut Hegbom, Rune Wiseth, Erik Madssen

    The purpose of the present study was to investigate the edge vascular response in patients treated with second-generation drug-eluting stents (DES) after 3 months of aerobic exercise intervention. Thirty-two patients with significant coronary artery disease underwent percutaneous coronary intervention with DES implantation prior to randomization to aerobic interval training (AIT, 14 patients) versus moderate continuous training (MCT, 18 patients). Plaque changes were assessed using grayscale and radiofrequency intravascular ultrasound at baseline and follow-up. The main endpoints were changes in plaque burden and necrotic core content in the 5-mm proximal and distal stent edges. Plaque burden in the distal stent edges decreased significantly in both groups (AIT: − 3.3%; MCT: − 0.4%, p = 0.01 for both), and more in the AIT group (p = 0.048). Necrotic core content decreased significantly in the distal stent edges in both groups (− 2.1 mm3 in AIT, − 0.3 mm3 in MCT, p = 0.01 for both), and more in the AIT group (p = 0.03). There were no significant changes in proximal stent edges or in in-stent geometry at follow-up. In this small study of patients treated with DES implantation, 3 months of aerobic exercise training demonstrated decreased plaque burden and necrotic core content in the distal stent edges, with larger reductions in the AIT group.